Almotriptan indications and usage: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 10: | Line 10: | ||
* Acute treatment of migraine headache pain in adolescents age 12 to 17 years with a history of migraine with or without aura, and who have migraine attacks usually lasting 4 hours or more | * Acute treatment of migraine headache pain in adolescents age 12 to 17 years with a history of migraine with or without aura, and who have migraine attacks usually lasting 4 hours or more | ||
Important limitations | ===Important limitations=== | ||
* Use only after a clear diagnosis of migraine has been established | * Use only after a clear diagnosis of migraine has been established | ||
Latest revision as of 01:55, 5 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]
Indications and Usage
Almotriptan is a 5HT1B/1D receptor agonist (triptan) indicated for:
- Acute treatment of migraine attacks in adults with a history of migraine with or without aura
- Acute treatment of migraine headache pain in adolescents age 12 to 17 years with a history of migraine with or without aura, and who have migraine attacks usually lasting 4 hours or more
Important limitations
- Use only after a clear diagnosis of migraine has been established
- In adolescents age 12 to 17 years, efficacy of Almotriptan on migraine-associated symptoms was not established
- Not intended for the prophylactic therapy of migraine
- Not indicated for the treatment of cluster headache